참고문헌
- Bussemakers MJ, van Bokhoven A, Mees SG, Kemler R, Schalken JA (1993). Molecular cloning and characterization of the human E-cadherin cDNA. Mol Biol Rep, 17, 123-128. https://doi.org/10.1007/BF00996219
- Choi IS, Wu TT (2005). Epigenetic alterations in gastric Carcinogenesis. Cell Res, 15, 247-54. https://doi.org/10.1038/sj.cr.7290293
- Correa P (1992). Human gastric carcinogenesis, a multistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res, 52, 6735-40.
- Du W, Wang S, Zhou Q, et al (2013). ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer. Oncogene, 32, 3319-28. https://doi.org/10.1038/onc.2012.359
- Enokida H, Shiina H, Urakami S et al (2005). Ethnic grouprelated differences in CpG hypermethylation of the GSTP1gene promoter among African-American, Caucasian and Asian patientswith prostate cancer. Int J Cancer, 116, 174-81. https://doi.org/10.1002/ijc.21017
- Galanter JM , Christopher RG, Sam SO, et al (2015). Methylation analysis reveals fundamental differences between ethnicity and genetic ancestry. Bio Rxiv.
- Guan Z, Zhang J, Song S, Dai D (2013). Promoter methylation and expression of TIMP3 gene in gastric cancer. Diagn Pathol, 8, 1-6.
- Graziano F, Arduini F, Ruzzo A, et al(2004). Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer. Clin Cancer Res, 10, 2784-9. https://doi.org/10.1158/1078-0432.CCR-03-0320
- Hu X, Sui X, Li L, et al (2013). Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers. J Pathol, 229, 62-73. https://doi.org/10.1002/path.4093
- Humar B, Blair V, Charlton A, et al (2009). E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Cancer Res, 69, 2050-6.
- Jemal A, Bray, Center M, Ferlay, Ward E, Forman D (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Kang GH, Lee HJ, Hwang KS, et al (2003). Aberrant CpG Island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol, 163, 1551-6. https://doi.org/10.1016/S0002-9440(10)63511-0
- Karayiannakis AJ, Syrigos KN, Chatzigianni E, et al (1998). Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer. Anticancer Res, 18, 4177-80.
- Lee TL, Leung WK, Chan MW et al (2002). Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res, 8, 1761-6.
- Machado JC, Oliveira C, Carvalho R, et al (2001). E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene, 20, 1525-8. https://doi.org/10.1038/sj.onc.1204234
- Oliveira C, Sousa S, Pinheiro H, et al (2009). Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterol, 136, 2137-48. https://doi.org/10.1053/j.gastro.2009.02.065
- Pandith AA, Siddiqi MA (2012). Burden of cancers in the valley of Kashmir, 5 year epidemiological study reveals a different scenario. Tumor Biol, 33, 1629-37. https://doi.org/10.1007/s13277-012-0418-z
- Parkin DM, Bray F, Ferlay J, Pisani P(2005) . Global cancer statistics 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
- Rao V, Ganesh B (1998). Estimate of cancer incidence in India in 1991. Indian J Cancer, 35, 10-18.
- Siegel R, Ma J, Zou Z, Jemal A(2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29. https://doi.org/10.3322/caac.21208
- Tahara T, Shibata T, Arisawa T, et al (2010). CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer. Anticancer Res, 30, 239-244.
- Takeichi M (1990). Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem, 59, 237-52. https://doi.org/10.1146/annurev.bi.59.070190.001321
- Van RF (2014). Beyond E-cadherin: roles of other cadherin superfamily members in cancer. Nat Rev Cancer, 14, 121-34. https://doi.org/10.1038/nrc3647
- Wang K, Yuen ST, Xu J, et al (2014). Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nature Genetics, 46, 573-82. https://doi.org/10.1038/ng.2983
- Wani M, Afroze D, Makhdoomi M, et al (2012). Promoter Methylation status of DNA repair gene (hMLH1) in gastric carcinoma patients of the Kashmir Valley. Asian Pac J Cancer Prev, 13, 4177-418. https://doi.org/10.7314/APJCP.2012.13.8.4177
- Yi Kim D, Kyoon Joo J, Kyu Park Y, et al (2007). E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis. J Surg Oncol, 96, 429-35 . https://doi.org/10.1002/jso.20732
- Yoo TH, Ryu BK, Lee MG, Chi SG (2013). CD81 is a candidate tumor suppressor gene in human gastric cancer. Cell Oncol, 36, 141-53. https://doi.org/10.1007/s13402-012-0119-z
- Yousuf A, Bhat MY, Pandith AA, et al (2014). MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area. Cell Oncol, 37, 245-52. https://doi.org/10.1007/s13402-014-0179-3
- Zhang KL, Sun Y, Li Y, et al (2008). Increased frequency of CpG island methylator phenotype and CDH1 methylation in a gastric cancer high-risk region of china. Transl Oncol 1, 28-35. https://doi.org/10.1593/tlo.07103
- Zheng Z, Pan J, Chu B, et al (1999). Down¬regulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol, 30, 458-66. https://doi.org/10.1016/S0046-8177(99)90123-5
- Zhu AL, Sonnenberg A (2012). Is gastric cancer again rising? J Clin Gastroenterol, 46, 804-6. https://doi.org/10.1097/MCG.0b013e3182604254
- Zouridis H, Deng N, Ivanova T, et al (2012). Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci Transl Med, 4, 156ra140.